Nadia Ben Fredj Selected Research

Nadia Ben Fredj Research Topics

Disease

7	Hypersensitivity (Allergy) 02/2024 - 08/2010
5	Drug Eruptions (Drug Eruption) 01/2023 - 05/2012
4	Exanthema (Rash) 02/2024 - 08/2010
4	Eosinophilia 02/2024 - 08/2010
3	Multiple Sclerosis 05/2017 - 06/2014
2	Tuberculosis (Tuberculoses) 02/2024 - 01/2021
2	Hyperthermia 02/2024 - 01/2023
2	Lymphadenopathy 02/2024 - 01/2023
2	Drug Hypersensitivity Syndrome 01/2023 - 12/2014
2	Drug Hypersensitivity (Drug Allergy) 07/2019 - 02/2016
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 04/2024
1	Urticaria (Hives) 02/2024
1	Hyperthyroidism 02/2024
1	Edema (Dropsy) 02/2024
1	Fever (Fevers) 02/2024
1	Autoimmune Pancreatitis 01/2023
1	COVID-19 01/2023
1	Arthritis (Polyarthritis) 01/2023
1	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 01/2023
1	Erythema Nodosum 01/2023
1	Subacute Thyroiditis (Thyroiditis, De Quervain) 01/2023
1	Low Back Pain (Lumbago) 01/2023
1	Guillain-Barre Syndrome 01/2023
1	Extrapulmonary Tuberculosis 06/2020
1	Blister (Bulla) 11/2019
1	Critical Illness (Critically Ill) 04/2019
1	Amenorrhea 12/2017
1	Neoplasm Metastasis (Metastasis) 12/2014
1	Virus Diseases (Viral Diseases) 06/2014
1	Hepatitis 02/2014
1	Human Influenza (Influenza) 05/2011

Drug/Important Bio-Agent (IBA)

3	Isoniazid (Ftivazide)FDA LinkGeneric 02/2024 - 06/2020
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2023 - 11/2019
3	Acetaminophen (Paracetamol)FDA LinkGeneric 12/2023 - 11/2019
2	beta-LactamsIBA 01/2023 - 12/2021
2	Cefotaxime (Kendrick)FDA LinkGeneric 01/2023 - 02/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2019 - 04/2019
2	Amoxicillin (Wymox)FDA LinkGeneric 04/2016 - 08/2010
1	Ertapenem (Invanz)FDA Link 04/2024
1	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 04/2024
1	Meropenem (Merrem)FDA LinkGeneric 04/2024
1	Propylthiouracil FDA Link 02/2024
1	Histamine Antagonists (Antihistamines)IBA 02/2024
1	Methimazole (Thiamazole)FDA LinkGeneric 02/2024
1	Pyrazinamide FDA LinkGeneric 02/2024
1	Ethambutol (Myambutol)FDA LinkGeneric 02/2024
1	Rifampin (Rifampicin)FDA LinkGeneric 02/2024
1	Gam-COVID-Vac vaccineIBA 01/2023
1	COVID-19 VaccinesIBA 01/2023
1	mRNA VaccinesIBA 01/2023
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2023
1	LactamsIBA 01/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023
1	Naproxen (Naprosyn)FDA LinkGeneric 01/2023
1	TeicoplaninIBA 01/2023
1	Penicillins (Penicillin)FDA Link 12/2021
1	PristinamycinIBA 11/2021
1	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 11/2021
1	Celecoxib (Celebrex)FDA Link 11/2019
1	Piroxicam (Feldene)FDA LinkGeneric 07/2019
1	Meloxicam (Mobic)FDA LinkGeneric 07/2019
1	Interleukin-10 (Interleukin 10)IBA 05/2017
1	Cell Surface ReceptorsIBA 05/2017
1	Interleukin-10 ReceptorsIBA 05/2017
1	CytokinesIBA 05/2017
1	HLA-G Antigens (HLA G)IBA 12/2016
1	3' Untranslated Regions (3' UTR)IBA 12/2016
1	Excipients (Suspending Agents)IBA 02/2016
1	Silicon Dioxide (Silica)FDA LinkGeneric 02/2016
1	Phenobarbital (Luminal)FDA Link 12/2014
1	Immunoglobulins (Immunoglobulin)IBA 06/2014
1	LigandsIBA 06/2014
1	KIR2DL2 ReceptorsIBA 06/2014
1	Albendazole (Albenza)FDA Link 02/2014
1	Levofloxacin (Levaquin)FDA Link 05/2012
1	VaccinesIBA 05/2011
1	Carbamazepine (Tegretol)FDA LinkGeneric 08/2010
1	Allopurinol (Remid)FDA LinkGeneric 08/2010

Therapy/Procedure

2	Therapeutics 02/2024 - 02/2014
1	Critical Care (Surgical Intensive Care) 12/2017